LCID
Lucid Group, Inc.
LCID lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
UXIN
Uxin Limited
There isn't enough reported data to score UXIN yet.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
UXIN Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
UXIN's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
UXIN PE Valuation
UXIN has no meaningful PE right now: it lost money over the past year.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
UXIN Forward outlook
There aren't enough analyst estimates for UXIN to show an outlook.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
UXIN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q1 2024 | -$0.17 | +$0.83 |
| Q1 2023 | -$1.00 | +$0.41 |
| Q1 2022 | -$1.41 | +$3.34 |
| Q4 2019 | -$33.66 | +$41.23 |
| Q4 2018 | -$74.89 | +$115.52 |
UXIN has the edge over LCID in the latest year-over-year earnings comparison.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over UXIN in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
UXIN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $311.7M | +39% |
| Q1 2024 | $206.3M | -33% |
| Q1 2023 | $309M | +103% |
| Q1 2022 | $151.9M | +54% |
| Q1 2021 | $98.7M | +533% |
| Q4 2019 | $238.3M | -52% |
| Q4 2018 | $497.6M | +373% |
| Q4 2017 | $105.1M | +96% |
UXIN's revenue has grown year over year for five quarters in a row: $312M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -4.6% | +13 points |
| Q2 2025 | -6.7% | +11 points |
| Q4 2024 | -12% | +3.8 points |
| Q1 2024 | -23% | +61 points |
| Q1 2023 | -17% | +2087 points |
| Q1 2022 | -18% | +63 points |
| Q3 2021 | -15% | +62 points |
| Q1 2021 | -84% | -18 points |
UXIN's operating margin was −4.6% last quarter, up 13 points from the same quarter a year ago, near the top of its range since 2016.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
UXIN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$54.3M | -$24.4M |
| Q1 2024 | -$41.3M | +$1.4M |
| Q1 2023 | -$42.7M | +$3.6M |
| Q1 2022 | -$46.3M | +$122.2M |
| Q1 2021 | -$168.5M | -$106.7M |
| Q4 2019 | -$186.2M | +$176.2M |
| Q4 2018 | -$362.5M | -$236M |
| Q4 2017 | -$126.5M | -$107.3M |
UXIN has burned cash in almost every quarter: −$150M over the past year, against −$341M the year before.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has the edge over UXIN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
UXIN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1525% | +2.1B shares |
| 1 year | +16320% | +2.2B shares |
| 3 years | +73705% | +2.2B shares |
UXIN has 2.2B diluted shares, up 16320% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2020 | $1.1M |
| Q4 2017 | — |
| Q3 2017 | — |
| Q2 2017 | — |
| Q1 2017 | — |
| Q4 2016 | — |
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UXIN Net Leverage
UXIN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
UXIN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 25.5 | Oversold |
| Stochastic | 9.9 | Oversold |
UXIN's weekly RSI is 26 (oversold) and its Stochastic is 10 (oversold).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
UXIN PE vs Consumer Cyclical Sector
UXIN has no meaningful PE right now: it lost money over the past year.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
UXIN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.01 | 24% below |
| 20 week MA | $1.21 | 36% below |
| 50 week MA | $2.28 | 66% below |
| 100 week MA | $3.11 | 75% below |
| 200 week MA | $6.53 | 88% below |
UXIN is in a downtrend: it's below all five of its weekly moving averages, and 88% below its 200-week average.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has the edge over UXIN on returns for 2026, with the stronger performance.
UXIN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $231.0 | $96.0 | -58% |
| 2021 | $96.0 | $147.0 | +53% |
| 2022 | $147.0 | $25.8 | -82% |
| 2023 | $25.8 | $7.01 | -73% |
| 2024 | $7.01 | $4.68 | -33% |
| 2025 | $4.68 | $3.82 | -18% |
| 2026 YTD | $3.82 | $0.77 | -80% |
UXIN has finished four years in a row lower, and it's down 80% so far in 2026.